Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TX Providers > Urologists

Dr. Mark Alan McCurdy, MD

(No ratings)

Specializes in: Urology (Urinary Tract Disease)

Baylor College of Medicine (1994)

Professional interests include: vasectomy, ureteroscopy, adult circumcision, and more.

801 West Interstate 20
Arlington, TX 76017

(817) 646-5200

Dr. Mark Alan McCurdy, MD is an urologist in Bedford, TX specializing in urology (urinary tract disease). He graduated from Baylor College of Medicine in 1994 and has 32 years of experience. Dr. Mark Alan McCurdy, MD is affiliated with Texas Health Resources, USMD Hospital at Arlington, Baylor Scott & White All Saints Medical Center - Fort Worth, Texas Oncology and Baylor Scott & White Health.

Office Locations

Baylor Scott & White Health

1615 Hospital Parkway Suite 204
Bedford, TX 76022

(817) 784-8268

open_in_new

Texas Health Resources

5450 Clearfork Main Street Suite 420
Fort Worth, TX 76109

(817) 784-8268

open_in_new

6100 Harris Parkway Suite 265
Fort Worth, TX 76132

(817) 346-6173

open_in_new

USMD Hospital at Arlington

801 West Interstate 20
Arlington, TX 76017

(817) 646-5200

open_in_new

Some issues Dr. Mark Alan McCurdy, MD can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Sacral Nerve Stimulation (SNS)

Sacral nerve stimulation (SNS), also called sacral neuromodulation, is a treatment for bladder and bowel problems. Using thin, insulated wires (electrodes) and a device called a neurostimulator, sacral nerve stimulation can deliver electrical signals to correct communication issues between the brain and the bladder. The electrical signals reach the sacral nerve, which is responsible for muscles that control the bladder and rectal sphincter. By targeting this nerve, sacral nerve stimulation can influence the activity of pelvic muscles to treat overactive bladder, fecal (bowel) incontinence, and chronic constipation. When diet or lifestyle changes, medication, and other conservative options fail to work, neurostimulation is an option.

SNS surgery has two parts. The first part is an evaluation phase, during which it is determined if neurostimulation is effective treatment option for patients. Patients lie on their stomachs while a temporary electrode lead, through which electrical signals will travel, is inserted into their lower back. A permanent lead may also be used, and it would remain in place should the trial period prove successful. The lead is connected to an external neurostimulator. The procedure takes approximately one hour and may be performed in a doctor's office, hospital, or surgical center. After the procedure, patients are required to keep a log of their toilet habits over approximately two weeks, and they may need to limit their activities during this time. If patients' symptoms do not improve after the trial, they may repeat the test phase or discuss other treatment options with their doctors.

If the trial stimulator is effective, patients will undergo the second phase of SNS surgery, which is permanent implantation. In the second stage of surgery, the temporary lead (if used) will be replaced with a permanent lead. Then the sacral nerve stimulator will be implanted subcutaneously (under the skin) in the upper buttock. Patients should be able to return home the day of their procedure.

If patients are sore after surgery, their doctors may give them medication. The sacral nerve stimulator will be programmed after the procedure, and when it is turned on, patients should feel a sensation similar to pulling, tapping, tingling, or pulsing. Patients will need to work with their doctors during follow-up appointments to determine the most effective settings for the stimulator. Patients will be given instructions on how to adjust it themselves at home. The stimulator is powered by a battery that will last approximately five years, after which it can be replaced.

Shock Wave Lithotripsy

Stones are formed when mineral deposits build up and harden in an organ or gland. For example, urine contains minerals that can form crystals and result in kidney or bladder stones. Stones can also occur in other parts of the body, like the mouth. Salivary gland stones form when the chemicals in the saliva harden and get stuck in the tiny ducts of the salivary glands. Pain and swelling are the most common symptoms associated with stones.

Lithotripsy is a procedure used to break up small stones. Shock wave lithotripsy, the most common type of lithotripsy and least invasive way of treating stones, does this using high-powered sound waves. This procedure can treat many types of stones in the body, but it is most frequently used for urinary stones, such as kidney and bladder stones.

Shock wave lithotripsy can be done in one of two ways. Conventionally, this procedure is performed when someone is sitting in a tub of water, and the sound waves travel through the water to their body. A more recent alternative is to send the shock waves through cushions while a patient is lying on a table. Although shock wave lithotripsy is not surgery and requires no cutting, the patient will be given anesthesia before the procedure. Their body should be able to pass the broken-up urinary stones naturally in their urine after treatment. For other types of stones, another minimally invasive procedure may be required to remove stone fragments left by shock wave lithotripsy.

In The News

“David is survived by his son, Dr. Mark McCurdy, wife Elizabeth, granddaughters Catherine and Grace McCurdy of Fort Worth, Texas, and grandchildren Jessica and Douglas Weaver from his daughter that...”—"David E. McCurdy, Ph.D., 73, of Northborough", Community Advocate, June 2017

Noteworthy Medicare Patient Procedures Performed by Dr. Mark Alan McCurdy, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 10%

By Volume:

minor procedures

In 2023, Dr. Mark Alan McCurdy, MD performed more minor procedures procedures for Medicare patients than 90% of providers in related specialties within Texas.

Top 25%

By Volume:

blood draw

lab tests

minimally invasive procedures

phlebotomy for lab tests

prostate-specific antigen test

By Affordability:

blood draw

blood draw for lab tests

diagnostic cystoscopy

phlebotomy for lab tests

In 2012, among providers in related specialties within Texas, Dr. Mark Alan McCurdy, MD performed more blood draw, lab tests, minimally invasive procedures, phlebotomy for lab tests, and prostate-specific antigen (PSA) test procedures for Medicare patients than 75% of them and he also had a list price for blood draw, blood draw for lab tests, diagnostic cystoscopy, phlebotomy for lab tests, prostate screening, screening PSA test, urinalysis, and venipuncture (phlebotomy) that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2012 were lab tests, urologic procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

blood draw	26
catheterization	24
diagnostic procedures	24
doctor visit	918
hormone therapy	107
hospital care	120
injections	110
inpatient care	120
lab tests	426
minimally invasive procedures	113
minor procedures	24
stent placement (stenting)	17
urologic procedures	375

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2013 were lab tests, urologic procedures, minimally invasive procedures and hormone therapy.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

catheterization	16
diagnostic procedures	29
doctor visit	845
hormone therapy	91
hospital care	72
injections	91
inpatient care	72
lab tests	427
minimally invasive procedures	130
minor procedures	29
stent placement (stenting)	17
urologic procedures	311

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	438
Female	147

**Ethnicity**
Non-Hispanic White	496
Black	52
Hispanic	25
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	260
From 75 to 84	204
85 and over	78
Less than 65	43

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2013

Hypertension	72
High Cholesterol	58
Stroke	5
Ischemic Heart Disease	36
Depression	19
Chronic Kidney Disease	29
Asthma	8
Osteoperosis	5
Atrial Fibrilation	12
Heart Failure	19
Chronic Obstructive Pulmonary Disease	16
Diabetes	29
Dementia	16
Cancer	22

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2014 were lab tests, urologic procedures, minimally invasive procedures and hospital care.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

catheterization	14
diagnostic procedures	20
doctor visit	814
hormone therapy	79
hospital care	109
injections	63
inpatient care	109
lab tests	504
minimally invasive procedures	130
minor procedures	20
stent placement (stenting)	20
urologic procedures	290

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	454
Female	129

**Ethnicity**
Non-Hispanic White	477
Black	58
Hispanic	29
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	254
From 75 to 84	215
85 and over	74
Less than 65	40

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2014

Hypertension	75
High Cholesterol	64
Stroke	6
Ischemic Heart Disease	38
Depression	19
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	7
Atrial Fibrilation	13
Heart Failure	20
Chronic Obstructive Pulmonary Disease	16
Diabetes	32
Dementia	15
Cancer	25

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2015 were lab tests, hospital care, inpatient care and urologic procedures.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

abdominal imaging	13
blood draw	56
diagnostic procedures	16
doctor visit	682
hormone therapy	21
hospital care	192
inpatient care	192
lab tests	204
minimally invasive procedures	97
minor procedures	16
stent placement (stenting)	20
ultrasound (sonogram)	13
urologic procedures	185

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	876
Female	222

**Ethnicity**
Non-Hispanic White	898
Black	116
Hispanic	54
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	480
From 75 to 84	430
85 and over	124
Less than 65	64

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2015

Hypertension	75
High Cholesterol	63
Stroke	8
Ischemic Heart Disease	40
Depression	24
Chronic Kidney Disease	38
Asthma	15
Osteoperosis	7
Atrial Fibrilation	12
Heart Failure	21
Chronic Obstructive Pulmonary Disease	17
Diabetes	35
Dementia	18
Cancer	25

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2016 were lab tests, urologic procedures, blood draw and inpatient care.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

abdominal imaging	25
blood draw	183
CT scan	11
diagnostic procedures	26
doctor visit	662
emergency care	11
hormone therapy	19
hospital care	154
inpatient care	154
lab tests	526
laser treatment	13
lithotripsy (stone fragmentation)	13
minimally invasive procedures	116
minor procedures	26
pelvic imaging	11
stent placement (stenting)	30
ultrasound (sonogram)	14
urologic procedures	205

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	471
Female	118

**Ethnicity**
Non-Hispanic White	496
Black	58
Hispanic	21
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	245
From 75 to 84	230
85 and over	81
Less than 65	33

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2016

Hypertension	75
High Cholesterol	61
Stroke	8
Ischemic Heart Disease	40
Depression	20
Chronic Kidney Disease	45
Asthma	19
Osteoperosis	5
Atrial Fibrilation	14
Heart Failure	20
Chronic Obstructive Pulmonary Disease	16
Diabetes	34
Dementia	21
Cancer	27

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2017 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

blood draw	200
catheterization	32
diagnostic procedures	24
doctor visit	635
hospital care	72
inpatient care	72
lab tests	628
minimally invasive procedures	96
minor procedures	24
urologic procedures	233

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	427
Female	111

**Ethnicity**
Non-Hispanic White	464
Black	39
Hispanic	20
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	224
From 75 to 84	201
85 and over	82
Less than 65	31

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2017

Hypertension	75
High Cholesterol	55
Stroke	6
Ischemic Heart Disease	41
Depression	20
Chronic Kidney Disease	40
Asthma	8
Osteoperosis	8
Atrial Fibrilation	14
Heart Failure	17
Chronic Obstructive Pulmonary Disease	16
Diabetes	31
Dementia	21
Cancer	25

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2018 were lab tests, urologic procedures, blood draw and inpatient care.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

biological response modifier (BRM) therapy	50
blood draw	265
catheterization	38
chemotherapy	50
diagnostic procedures	24
doctor visit	571
emergency care	13
hospital care	111
inpatient care	111
lab tests	819
minimally invasive procedures	102
minor procedures	24
stent placement (stenting)	13
urologic procedures	285

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	423
Female	114

**Ethnicity**
Non-Hispanic White	447
Black	52
Hispanic	26
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	229
From 75 to 84	209
85 and over	68
Less than 65	31

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2018

Hypertension	75
High Cholesterol	65
Stroke	7
Ischemic Heart Disease	41
Depression	21
Chronic Kidney Disease	45
Asthma	9
Osteoperosis	5
Atrial Fibrilation	15
Heart Failure	21
Chronic Obstructive Pulmonary Disease	18
Diabetes	33
Dementia	17
Cancer	26

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2019 were lab tests, urologic procedures, blood draw and minor procedures.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

anorectal procedures	20
blood draw	235
catheterization	25
diagnostic procedures	33
doctor visit	1016
hormone therapy	84
hospital care	33
injections	23
inpatient care	33
lab tests	1001
minimally invasive procedures	59
minor procedures	97
preventive care	27
suprapubic catheter replacement	42
ultrasound (sonogram)	19
urologic procedures	294
vascular procedures	19

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	653
Female	229

**Ethnicity**
Non-Hispanic White	734
Black	67
Hispanic	47
Asian	14
Other	20
Native American	0

**Age**
From 65 to 74	448
From 75 to 84	296
85 and over	89
Less than 65	49

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2019

Hypertension	73
High Cholesterol	66
Stroke	5
Ischemic Heart Disease	39
Depression	23
Chronic Kidney Disease	35
Asthma	7
Osteoperosis	7
Atrial Fibrilation	15
Heart Failure	17
Chronic Obstructive Pulmonary Disease	12
Diabetes	32
Dementia	13
Cancer	20

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2020 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

blood draw	142
diagnostic procedures	12
doctor visit	729
emergency care	12
hormone therapy	31
injections	28
lab tests	508
lithotripsy (stone fragmentation)	12
minimally invasive procedures	62
minor procedures	43
preventive care	33
urologic procedures	196

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	478
Female	81

**Ethnicity**
Non-Hispanic White	468
Black	43
Hispanic	25
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	271
From 75 to 84	198
85 and over	55
Less than 65	35

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2020

Hypertension	73
High Cholesterol	65
Stroke	6
Ischemic Heart Disease	40
Depression	18
Chronic Kidney Disease	37
Asthma	5
Osteoperosis	4
Atrial Fibrilation	13
Heart Failure	17
Chronic Obstructive Pulmonary Disease	11
Diabetes	34
Dementia	10
Cancer	21

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2021 were lab tests, urologic procedures, blood draw and minor procedures.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

blood draw	152
doctor visit	811
hormone therapy	65
injections	41
lab tests	604
minimally invasive procedures	44
minor procedures	65
preventive care	18
urologic procedures	154

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	474
Female	69

**Ethnicity**
Non-Hispanic White	455
Black	39
Hispanic	28
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	278
From 75 to 84	194
85 and over	47
Less than 65	24

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2021

Hypertension	74
High Cholesterol	70
Stroke	5
Ischemic Heart Disease	39
Depression	22
Chronic Kidney Disease	38
Asthma	6
Osteoperosis	4
Atrial Fibrilation	13
Heart Failure	14
Chronic Obstructive Pulmonary Disease	10
Diabetes	37
Dementia	9
Cancer	23

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX during 2022 were lab tests, blood draw, urologic procedures and minor procedures.

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

blood draw	265
diagnostic procedures	13
doctor visit	1021
hormone therapy	68
injections	45
lab tests	845
minimally invasive procedures	65
minor procedures	81
preventive care	21
urologic procedures	246

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	632
Female	150

**Ethnicity**
Non-Hispanic White	656
Black	46
Hispanic	38
Asian	12
Other	30
Native American	0

**Age**
From 65 to 74	406
From 75 to 84	272
85 and over	85
Less than 65	19

Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD in 2022

Hypertension	75
High Cholesterol	75
Stroke	7
Ischemic Heart Disease	30
Depression	17
Chronic Kidney Disease	25
Asthma	8
Osteoperosis	8
Atrial Fibrilation	18
Heart Failure	14
Chronic Obstructive Pulmonary Disease	13
Diabetes	35
Dementia	6
Cancer	29

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Mark Alan McCurdy, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mark Alan McCurdy, MD treated as an urologist in Bedford, TX were lab tests, urologic procedures, blood draw and inpatient care.

abdominal imaging	19
anorectal procedures	20
biological response modifier (BRM) therapy	50
blood draw	169
catheterization	24
chemotherapy	50
CT scan	11
diagnostic procedures	22
doctor visit	791
emergency care	12
hormone therapy	62
hospital care	107
injections	57
inpatient care	107
lab tests	590
laser treatment	13
lithotripsy (stone fragmentation)	12
minimally invasive procedures	92
minor procedures	40
pelvic imaging	11
preventive care	24
stent placement (stenting)	19
ultrasound (sonogram)	15
urologic procedures	252
vascular procedures	19

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Mark Alan McCurdy, MD.

**Gender**
Male	484
Female	124

**Ethnicity**
Black / African American	51
Asian / Pacific Islander	2
Non-Hispanic White	508
Hispanic	28
Native American / Alaskan Native	0
Other	4

**Age**
75 to 84	222
85 and over	71
Less than 65	33
65 to 74	281

Average of Total of Conditions of Medicare patients treated by Dr. Mark Alan McCurdy, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Mark Alan McCurdy, MD treated were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.

Hypertension	67
High Cholesterol	58
Stroke	5
Ischemic Heart Disease	34
Depression	18
Chronic Kidney Disease	33
Asthma	8
Osteoporosis	5
Heart Failure	16
Chronic Obstructive Pulmonary Disease	13
Diabetes	30
Atrial Fibrillation	12
Cancer	22
Dementia	13

Education & Training

Dr. Mark Alan McCurdy, MD graduated from Baylor College of Medicine in 1994. He completed residency at Baylor College of Medicine Affiliated Hospitals. He is certified by the Urology - - Urology- American Board of Urology and has a state license in Texas.

Medical School: Baylor College of Medicine (1994)

Residency: Baylor College of Medicine Affiliated Hospitals

Board Certification: Urology - - Urology- American Board of Urology

Licensed In: Texas

Affiliations & Hospitals

Dr. Mark Alan McCurdy, MD is associated with these hospitals and organizations:

Texas Health Resources

USMD Hospital at Arlington

Baylor Scott & White All Saints Medical Center - Fort Worth

Texas Oncology

Baylor Scott & White Health

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Mark Alan McCurdy, MD appears to accept the following insurance providers: Baylor Scott & White Health Plan-BSW SeniorCare Advantage HMO, Baylor Scott & White Health Plan-BSW Solutions PPO, Centivo Network-Centivo Network - Baylor Scott & White Premier, Baylor Scott & White Health Plan-BSWH Employee Network Premium (PPO)/ HDHP, Baylor Scott & White Health Plan-BSW Plus PPO-Individual/Family, Catalyst Health Group-Catalyst Health - Baylor Scott & White Preferred, Baylor Scott & White Health Plan-BSW Plus PPO-Group, Baylor Scott & White Health Plan-BSW Premier HMO-Individual/Family, Baylor Scott & White Health Plan-McLane Group Network, Baylor Scott & White Health Plan-BSWH Employee Network (SEQA & EQA), Nebraska Furniture Mart-Emerald, Baylor Scott & White Health Plan-BSW Plus HMO-Group, Baylor Scott & White Health Plan-BSW Plus HMO-Individual/Family, Baylor Scott & White Health Plan-HMO Network-Group, Baylor Scott & White Health Plan-BSW SeniorCare Advantage PPO, Prism Electric-BSW Premier - Prism, Baylor Scott & White Health Plan-BSW Access PPO, Nebraska Furniture Mart-Pearl, Baylor Scott & White Health Plan-EPO Network-Individual/Family, Baylor Scott & White Health Plan-Pyco Industries Employee Plan, Baylor Scott & White Health Plan-BSW Premier PPO, Baylor Scott & White Health Plan-PPO Network-Group, Baylor Scott & White Health Plan-HMO Network-Individual/Family, Nebraska Furniture Mart-Onyx and Baylor Scott & White Health Plan-BSW Premier HMO-Group.

Insurance Accepted by Provider includes:

According to our sources, Dr. Mark Alan McCurdy, MD accepts the following insurance providers:

Baylor Scott & White Health Plan-BSW SeniorCare Advantage HMO

Baylor Scott & White Health Plan-BSW Solutions PPO

Centivo Network-Centivo Network - Baylor Scott & White Premier

Baylor Scott & White Health Plan-BSWH Employee Network Premium (PPO)/ HDHP

Baylor Scott & White Health Plan-BSW Plus PPO-Individual/Family

Catalyst Health Group-Catalyst Health - Baylor Scott & White Preferred

Baylor Scott & White Health Plan-BSW Plus PPO-Group

Baylor Scott & White Health Plan-BSW Premier HMO-Individual/Family

Baylor Scott & White Health Plan-McLane Group Network

Baylor Scott & White Health Plan-BSWH Employee Network (SEQA & EQA)

Nebraska Furniture Mart-Emerald

Baylor Scott & White Health Plan-BSW Plus HMO-Group

Baylor Scott & White Health Plan-BSW Plus HMO-Individual/Family

Baylor Scott & White Health Plan-HMO Network-Group

Baylor Scott & White Health Plan-BSW SeniorCare Advantage PPO

Prism Electric-BSW Premier - Prism

Baylor Scott & White Health Plan-BSW Access PPO

Nebraska Furniture Mart-Pearl

Baylor Scott & White Health Plan-EPO Network-Individual/Family

Baylor Scott & White Health Plan-Pyco Industries Employee Plan

Baylor Scott & White Health Plan-BSW Premier PPO

Baylor Scott & White Health Plan-PPO Network-Group

Baylor Scott & White Health Plan-HMO Network-Individual/Family

Nebraska Furniture Mart-Onyx

Baylor Scott & White Health Plan-BSW Premier HMO-Group

Ratings & Reviews

Dr. Mark Alan McCurdy, MD does not have any reviews yet, be the first to leave a review of Dr. Mark Alan McCurdy, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mark Alan McCurdy, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Astellas Pharma US Inc	$1,774 Myrbetriq $903	XTANDI $302	Vesicare $196	TARCEVA $10	$364
Auxilium Pharmaceuticals, Inc.	$1,271 TESTIM $739	XIAFLEX $254	TESTOPEL $161	STENDRA $117
Boston Scientific Corporation	$549 GENERAL BPH $182	GENERAL THERAPIES $141	ARTIFICIAL URINARY SPHINCTER $128	ADVANTAGE FIT $34	LITHOVUE $29	Other $37
NeoTract Inc.	$529 Urolift - UL400 $529
Axonics, Inc.	$489 Axonics $376	Axonics r-SNM System $113
Other	$3,891 PROVENGE $741	Sacral Nerve Stimulation - Neuro $363	Endocare Cryocare System $210	Lupron $178	iTIND System $155	Other $2,244

**Types of Payments**
Food and Beverage	$8,130
Education	$373

Biography

Dr. Mark McCurdy is a physician who specializes in urology (urinary tract disease). He studied medicine at Baylor College of Medicine. Dr. McCurdy completed his residency training at a hospital affiliated with Baylor College of Medicine. Clinical interests for Dr. McCurdy include shock wave lithotripsy, second opinions, and low testosterone (male hypogonadism). In addition to English, he speaks Spanish. His professional affiliations include Texas Health Resources, Baylor Scott & White All Saints Medical Center - Fort Worth, and Texas Oncology.